RS2 Healthcare Partners has completed an investment in KMM Group, a precision contract manufacturer. The company machines complex, tight-tolerance components for medical device makers, using CNC machining, precision grinding, Swiss screw machining and electrical discharge machining, along with cleanroom services. The company is FDA registered and ISO 13485 certified for medical device quality management. It is based in Hatboro, Pa.
Co-founders John Shegda and Eric Wilhelm remain with the company. Shegda becomes chief technology officer, and Wilhelm becomes executive vice president of business transformation and organizational capability. J. Mark King, who previously ran another RS2 portfolio company, becomes president and CEO. RS2, a Boston private equity firm founded in 1989, invests only in lower-middle-market healthcare companies and has raised $1.6 billion in total capital commitments since inception.
